REVA PHARMA, is a fully integrated Healthcare and Pharmaceutical organization. Licensing, Product Development, Contract Manufacturing and Healthcare Services form the main activities of the company. Its operations and initiatives are backed up by regulatory approved infrastructure, which help to offer its partners, Products & Services complying with cGMP, GLP & EHS standards. It has carved out a name for itself in the Healthcare space across geographies for Reliability, Transparency and Trust.

Since incorporation in 2009, it has moved up in the industry ranking, with emphasis on its operations in Regulated, Expanding and Emerging markets. We have fulfilled our promise of providing value added products and services to our clients with rewarding partnerships.

National Healthcare Leadership Congress & Awards

Dr Gurpreet Sandhu, CEO and founder of Reva Pharma receiving Pharma Leadership Award endorsed by the World Federation of Healthcare Professionals on 28th September 2019 at the Taj Mahal Hotel, New Delhi.


"Our Mission is to provide Quality Pharmaceutical products and Healthcare services to our global business partners, ensuring highest standards in manufacturing and laboratory practices as well as compliance to Environment, Health and Safety norms. We are bound by our motto: Caring for Healthier Lives.

Our Vision is to be the permanent partner of choice for the products and services that we offer, by creating environment of Reliability, Transparency and Trust."


Our flagship markets are Japan, USA, Germany, Italy and Korea. We hold partnerships and alliances with Innovators, Biological, and Generic organizations the areas of Licensing, CRAM and API’s.

Research & Development

Research and Development is one of the major pillars on which a successful and customer oriented organization is built. We at Reva Pharma view R&D capabilities as a vital component of its ...

Regulatory Accreditations

REVA operates according to current Good Manufacturing and Laboratory Practice (cGMP and GLP). Our API and FDF manufacturing facilities have received regulatory approval from the following major health authorities.


Reva Pharma Monthly Newsletters



From March 2021, Pharma Firms Marketing Drugs Will Be Held R...

18 February 2020

Pharmaceutical companies that market drugs will now fall under the ambit of the Drugs and Cosmetics Act (DCA),...

Council for Healthcare and Pharma Emphasizes Urgent Need to ...

17 February 2020

The Council for Healthcare and Pharma today cited the urgent need to strengthen the system for the treatment o...

I Knocked On Hell's Door": What It Feels Like To Catch The C...

14 February 2020

For one coronavirus patient at ground zero of the outbreak, the journey from infection to recovery was a night...